Quick Answer
Arcus Biosciences, Inc. reported Total Revenue of $247.00 million for the year ending 2025.
- Arcus Biosciences, Inc. showed a decrease of -4.3% in Total Revenue from 2024 to 2025.
- This data is from Arcus Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2017 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2017: $163.0 thousand | Q4 2017: $1.25 million | Q1 2018: $1.25 million | Q2 2018: $1.25 million | Q3 2018: $4.29 million | Q4 2018: $1.56 million | Q1 2019: $1.75 million | Q1 2019: $1.75 million | Q2 2019: $1.75 million | Q2 2019: $1.75 million | Q3 2019: $1.75 million | Q3 2019: $1.75 million | Q4 2019: $9.75 million | Q1 2020: $1.75 million | Q2 2020: $1.75 million | Q3 2020: $64.53 million | Q1 2021: $9.46 million | Q2 2021: $9.46 million | Q3 2021: $9.46 million | Q1 2022: $18.00 million | Q2 2022: $27.00 million | Q3 2022: $33.00 million | Q1 2023: $25.00 million | Q2 2023: $29.00 million | Q3 2023: $32.00 million | Q1 2024: $145.00 million | Q1 2024: $145.00 million | Q2 2024: $39.00 million | Q2 2024: $39.00 million | Q3 2024: $48.00 million | Q3 2024: $48.00 million | Q1 2025: $28.00 million | Q2 2025: $160.00 million | Q3 2025: $26.00 million.
- Over the full 13 years of available data (2017 to 2025), Arcus Biosciences, Inc.'s Total Revenue has grown by 17,380.5%.
- Historical annual values: Fiscal year 2025: $247.00 million | Fiscal year 2024: $258.00 million | Fiscal year 2023: $117.00 million | Fiscal year 2023: $117.00 million | Fiscal year 2022: $112.00 million | Fiscal year 2022: $112.00 million | Fiscal year 2021: $383.00 million | Fiscal year 2020: $78.00 million | Fiscal year 2019: $15.00 million | Fiscal year 2019: $15.00 million | Fiscal year 2018: $8.35 million | Fiscal year 2018: $8.35 million | Fiscal year 2017: $1.41 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: